UVA LVG Seed Fund Portfolio

Ceres Nanosciences, Inc.

Ceres Nanosciences Inc. (“Ceres”) is engaged in the research, development, and commercialization of innovative sample preparation products and diagnostic tests, based on its proprietary Nanotrap® particle platform. The Nanotrap® particles capture, enrich and preserve the most valuable biomarkers, enabling early and accurate detection of diseases such as cancer, cardiac, neurological, and infectious diseases, resulting in improved patient outcomes and reduced health care costs. 

Website: http://www.ceresnano.com/

510Kardiac Devices, Inc.

510 Kardiac is an early stage medical device company developing novel technologies for cardiovascular surgical procedures. The company was co-founded by Dr. Scott Lim, an interventional cardiologist and the Director of the Advanced Cardiac Valve Center at the University of Virginia Health System and the company’s current CEO, Jaime Sarabia, a mechanical engineer with more than 18 years of experience in medical device ventures.

Mission Secure

Mission Secure, Inc. (MSi) provides unprecedented control system cyber security visibility AND protection. The patented* MSi Platform has been conceived, developed and deployed over the past seven years by a world class team of cyber security professionals, control system engineers, PhDs, military and business experts. Our team is committed to protecting critical physical assets, and the control systems that monitor and operate them, in defense, energy and transportation.

Website: http://www.missionsecure.com/

TearSolutions

Discovered by UVA Professor of Cell Biology and Ophthalmology Dr. Gordon Laurie, TearSolutions' first-in-class therapy is a synthetic form of the protein lacritin which targets the root causes of dry-eye disease. 

Website: http://www.tearsolutions.com/H...

TypeZero Technologies, Inc.

Digital health and personalized medicine company dedicated to revolutionizing the treatment and management of type 1 and type 2 diabetes.

Website: typezero.com